0 CHECKOUT

PRODUCT FILTERS

REGION

1,335
665
662
578
578

COUNTRY

563
139
83
81
80

CATEGORIES

  • 353
  • 265
  • 257
  • 254
  • 216
  • 209
  • 181
  • 162
  • 160
  • 148
  • 145
  • 136
  • 100
  • 98
  • 42

PRICE

586
1,160
1,961
3,868

PUBLISHED

198
1,207
2,009
3,868

PRODUCT TYPE

3,057
361
244
165
37
2
1
1

Oncology Drugs

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) & Application - Global Forecasts to 2020

"Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) & Application (Cardiovascular, Cancer, Pain Management, Cosmetic Surgery,...

Published:  February 2016
Price:  From

Global Oncology Ablation Market Outlook: 2015-2020 (2nd Edition)

Oncology Ablation is the minimal invasive treatment that is used to destroy or inactive the cancer cells and tumors. The market for oncology ablation is on the rise due to increasing number of cancer...

Published:  March 2016
Price:  From

Immunotherapy Drugs Market by Type of Drug, Epidemiology, Regulatory and Pipeline Analysis - Global Forecast to 2020

In this report, the immunotherapy market is segmented into types of drugs and region. By types of drug, the market is further subsegmented into antibodies, interferons, interleukins, vaccines and checkpoint...

Published:  December 2015
Price:  From

Malignant Melanoma Pricing and Reimbursement

With several new high cost melanoma drugs available, payer decisions on whether patients can access those drugs and under what conditions are becoming more important than ever. This report covers both...

Published:  September 2015
Price:  From

Carcinoembryonic Antigen (CEA) Market Analysis by Application (Colorectal, Pancreatic, Ovarian, Breast, Thyroid Cancer) and Segment Forecasts To 2022

Global carcinoembryonic antigen market is expected to reach USD 2.56 Billion by 2022. Constant technological advancements pertaining to the development of novel biomarkers which can be used in combination...

Published:  June 2015
Price:  From

Glioblastoma Multiforme Treatment (GBM) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022

Glioblastoma multiforme (GBM) is the most frequent and lethal primary brain tumor in adults. The current treatment modalities available in the market are surgical resection followed by chemotherapy...

Published:  June 2015
Price:  From

Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

The report on breast cancer therapeutics: pipeline analysis market studies the future market of breast cancer drugs on the basis of the molecules which are currently under pipeline. Breast cancer usually...

Published:  August 2015
Price:  From

World Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics - Market Opportunity and Forecast, 2014 - 2020

Castration-Resistant Prostate Cancer (CRPC) or Hormone Refractory Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after administering androgen deprivation therapy (ADT), is gaining...

Published:  July 2015
Price:  From

Oncology Pathways in the US - Friend or Foe for Pharma?

The costs of treating cancer in the US are spiralling upward, and payers have taken notice. This report takes a detailed look at the growing focus on value and quality that is driving greater use of...

Published:  July 2015
Price:  From

LAMEA Oncology/Anti-cancer Drugs Market - Opportunities and Forecasts, 2014 - 2021

Oncology/Anti-cancer drugs are used for treating various cancer types for improving and prolonging a patients survival time. Biological drugs, based on monoclonal antibodies (mAbs) would emerge as a...

Published:  February 2016
Price:  From

HPAPIs and Cytotoxic Drugs Manufacturing Market (2nd Edition), 2016 - 2026

The ‘HPAPIs and Cytotoxic Drugs Manufacturing Market, 2016-2026 (2nd edition)’ report provides an extensive study of the rapidly growing manufacturing market of HPAPIs and cytotoxic drugs. Due to their...

Published:  March 2016
Price:  From

Global Cancer Stem Cell Therapy Market Outlook 2020

Investigators discovered stem cells during their quest to find innovative cell therapy methods which could offer edge over prevailing modalities. These cells have ability to divide several times without...

Published:  April 2016
Price:  From

Global Malignant Melanoma Drug Market & Clinical Pipeline Insight

Investigators are trying to develop innovative therapeutics for the treatment of malignant melanoma with high safety and efficacy. Surgery has remained the corner stone of cancer treatment including...

Published:  May 2016
Price:  From

Colorectal Cancer Therapeutics Market in APAC 2015-2019

About colorectal cancer Colorectal cancer refers to malignancies that originate in the rectum or the colon. It is also known as bowel cancer. Formation of adenocarcinomas is the most common feature...

Published:  December 2015
Price:  From

Global Cervical Cancer Market 2015-2019

About cervical cancer Cervical cancer is the abnormal growth of cancerous cells in the tissues of the cervix. It is the world's fourth most common cause of death in women. The disease can be classified...

Published:  September 2015
Price:  From

Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019

About non-small cell lung cancer therapeutics Non-small cell lung cancer occurs when normal cells grow and multiply without control after undergoing a cell transformation. Lung cancer is the leading...

Published:  October 2015
Price:  From

Global Colorectal Cancer Drugs Market 2015-2019

About Colorectal Cancer Colorectal cancer refers to malignancies that originate in the rectum or the colon. It is also known as bowel cancer. Formation of adenocarcinomas is the most common feature...

Published:  June 2015
Price:  From

Global Kidney Cancer Drugs Market 2015-2019

About Kidney Cancer Kidney cancer also known as renal cancer affects the kidney cells. RCC is the most common form of kidney cancer in adults and Wilms' tumor in children. The exact cause of the disease...

Published:  July 2015
Price:  From

T-Cell Immunotherapy Market, 2015-2030

This report provides an extensive study of the field of T-cell immunotherapy. With no marketed products, this emerging field is still in its infancy; the report provides a comprehensive view of the...

Published:  October 2015
Price:  From

Antibody Drug Conjugates Market (3rd Edition)

The “Antibody Drug Conjugates Market (3rd edition), 2015-2025” report provides a comprehensive analysis of the current market landscape and future outlook of the growing pipeline of ADCs. The ADC market...

Published:  December 2015
Price:  From
Loading Indicator

Our Clients